Business
Director/PDMR Shareholding
Director/PDMR Shareholding.
About this update from Ironveld Plc
[{"type":"text","content":"\n \nRNS Number : 9365T Ironveld PLC 09 July 2018 \n\n9 July 2018\nIronveld Plc\n(\"Ironveld\" or the \"Company\")\nNotification of Transaction of Person Discharging Managerial Responsibilities (\"PDMRs\")\n \n \n\n\n\n\n1\n \n\n\nDetails of the person discharging managerial responsibilities / person closely associated\n \n\n\n\n\na)\n \n\n\nName\n \n\n\nRupert Fraser\n\n\n\n\n2\n \n\n\nReason for the notification\n \n\n\n\n\na)\n \n\n\nPosition/status\n \n\n\nNon-Executive Director\n\n\n\n\nb)\n \n\n\nInitial notification /Amendment\n \n\n\nInitial notification\n\n\n\n\n3\n \n\n\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\n \n\n\n\n\na)\n \n\n\nName\n \n\n\nIronveld plc\n\n\n\n\nb)\n \n\n\nLEI\n \n\n\n2138004LU52LQBNXG604\n \n\n\n\n\n4\n \n\n\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n \n\n\n\n\na)\n \n\n\nDescription of the financial instrument, type of instrument\nIdentification code\n \n\n\nOrdinary Shares of 1p each\n \nGB0030426455 \n\n\n\n\nb)\n \n\n\nNature of the transaction\n \n \n\n\nSale of shares\n\n\n\n\nc)\n \n\n\nPrice(s) and volume(s)\n \n\n\n \n\n\n\n\nPrice(s)\n \n\n\nVolume(s)\n\n\n\n\n2.35p\n\n\n500,052\n\n\n\n\n \n \n\n\n\n\nd)\n \n\n\nAggregated information\n- Aggregated volume\n- Price\n \n\n\n \nN/A (Single transactions)\n \n \n\n\n\n\ne)\n \n\n\nDate of the transaction\n \n \n\n\n27 June 2018\n\n\n\n\nf)\n \n\n\nPlace of the transaction\n \n \n\n\nLondon Stock Exchange, XLON\n\n\n\n\n \n \n\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com. END DSHUGUACMUPRGAR\n ","length":9489,"tagName":"div"}]